Insights On Trial Design

  1. The Importance Of Technology And Interconnectivity In Clinical Trials 6/10/2022

    Interoperability, connectivity, integrations are terms that are used quite frequently in industries that rely on technology. Learn why the clinical trial industry is no exception in the available blog.

  2. 4 Reasons Decentralized Trials Are Here To Stay 7/16/2021

    Although the pandemic isn’t behind us, trends are suggesting that decentralized trials are here to stay. But what does the future of decentralized clinical trials look like? This article explores emerging trends resulting from decentralized trials during COVID-19 and what they suggest about the future of DCT.

     

  3. Continuing Clinical Research Innovations After COVID-19 3/16/2021

    The COVID-19 pandemic has made the benefits of decentralized or hybrid trial models even more obvious, and as travel restrictions, social distancing and the overall strain on the healthcare system became more evident, the FDA updated regulations to fast-track research, openly recognizing the value of alternative technology such as virtual trial capabilities in clinical research. This webinar will explore how COVID-19 pushed the industry to adapt to tech-enabled solutions for patients and sponsors.

  4. Imaging In Clinical Trials: Pitfalls And Promises 10/27/2022

    In this webinar, attendees will learn how experts apply imaging science and operational expertise to identify and manage the inherent risks to capturing complete and high-quality central review data of study endpoints.

  5. Access To A Diverse Patient Population Can Solve Clinical Research’s Diversity Challenges 1/31/2022

    Increasing diversity in clinical research has consistently been a challenge. Despite increased public awareness of this issue and repeated efforts to remedy it, clinical trials still do not adequately represent the U.S. population. Find out how a diverse patient population can solve diversity challenges in clinical research.

  6. Global Pharma Saves 4 Months Recruitment Efforts With Digital Campaigning 7/1/2021

    A large global pharma initiated a phase III study testing the efficacy of combining two existing drugs in overactive bladder patients. The study planned to enroll 3,500 patients worldwide a 10-month period across and included sites in multiple countries in the Nordic region. Read how engaging Trialbee from study start to ensured enrollment deadlines were met as planned.

  7. CRO Leverages Partnership With Integrated Central IBC To Initiate Sites In COVID-19 Vaccine Research 5/11/2021

    The COVID-19 pandemic forced a CRO to reimagine what was possible as it became clear traditional timelines would not be sufficient to move the new COVID vaccines through clinical trials and to the public at warp speed. Working with Advarra, they were able accelerate review times so the COVID vaccine trial sites could progress through site selection, IRB/IBC submission, approval, drug shipment, and complete site initiation visits in record time.

  8. Benefits Of Simulation Training For Clinical Trial Sites 9/1/2021

    Today’s complex clinical research challenges require creative solutions. Using slide deck lectures won’t get you there. Pro-ficiency delivers a unique, state-of-the-art simulation approach that helps investigative sites deliver consistently on your study.

  9. Antibody-Drug Conjugates In Oncology: Key Considerations And Future Trends 10/13/2022

    In this blog, explore the current landscape of antibody-drug conjugates, including their benefits, limitations, key considerations for clinical trials, and potential future trends.

  10. Diversity In Clinical Research: Improving Clinical Trial Representation With High-Quality Training 10/27/2021

    Over the last several years, the pharma industry has become increasingly focused on issues of diversity. This has been reflected in regulatory guidelines and in the clinical trial recruitment phase of new drug research and development. However, relatively little attention has gone to diversity within the clinical research workforce, which many industry insiders have suggested can significantly enhance study population diversity.